A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine

Clinical trial NCT06974565 · COMPLETED

Trial details

NCT number: NCT06974565
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Chronic Liver Disease Healthy Participants

Start date: 2025-05-12
Primary completion: 2025-07-18
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.